[The risk of intravenous treatment with hyaluronidase from a dermatological viewpoint].
D000707:Anaphylaxis / Q000139:chemically induced; D004341:Drug Evaluation; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000008:administration & dosage / Q000009:adverse effects*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D052256:Tendinopathy / Q000188:drug therapy
D006821:Hyaluronoglucosaminidase
Zum Behandlungsrisiko bei intravenöser Hyaluronidasetherapie aus dermatologischer Sicht